defining osimertinib’s value in treating egfr nsclc
Published 6 years ago • 111 plays • Length 4:39Download video MP4
Download video MP3
Similar videos
-
5:26
osimertinib’s value in egfr-mutant nsclc
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
0:50
targeted option for non-small cell lung cancer #2023 #oncology #lungcancer
-
3:20
egfr mutated nsclc disease progression on osimertinib - 2022 program: targeted therapies forum
-
2:43
post-osimertinib treatment options for egfr nsclc - targeted therapies in lung cancer 2023
-
4:04
treating with osimertinib in egfr-mutated nsclc
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
5:24
case 4: egfr mutation analysis post-osimertinib
-
1:02
osimertinib for treatment of egfr lung cancer
-
6:55
case 4: treating egfr nsclc after osimertinib
-
3:09
case 2: osimertinib in egfr-mutated lung cancer
-
3:59
osimertinib for egfr t790m resistance mutations in nsclc
-
5:52
treatment of egfr nsclc after osimertinib
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
0:48
investigating osimertinib for brain activity in egfr-mutated lung cancer
-
1:15
osimertinib improves survival in egfr nsclc, poses new challenges for resistance
-
2:30
acquired resistance to osimertinib in egfr nsclc - 2022 program: targeted therapies forum - english
-
0:53
ramalingam compares third generation egfr tki osimertinib to older agents in nsclc